Income Statement
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $85K | — | — |
| Cost of Revenue | $2K | — | — |
| Gross Profit | $84K | — | — |
| R&D Expense | $402K | — | -70.3% |
| SG&A Expense | $1.5M | — | -18.2% |
| Operating Income | -$1.8M | — | +43.4% |
| Pre-tax Income | -$1.4M | — | -115.6% |
| Net Income | -$1.4M | — | -115.6% |
| EPS (Basic) | -$0.18 | — | -105.9% |
| EPS (Diluted) | -$0.18 | — | -105.9% |
Balance Sheet
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $39K | -81.0% | -96.7% |
| Accounts Receivable | $16K | +205.8% | +1464.0% |
| Inventory | $24K | +0.0% | +0.0% |
| Current Assets | $1.4M | +73.2% | -48.1% |
| Total Assets | $5.3M | +11.0% | -19.9% |
| Total Liabilities | $13.6M | +13.5% | -27.8% |
| Stockholders' Equity | -$8.3M | -15.1% | +32.1% |
Cash Flow
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$142K | — | +93.9% |
| Investing Cash Flow | -$24K | — | +40.3% |
| Financing Cash Flow | $199K | — | +0.0% |